Page 92 - AN-2-3

Advanced Neurology Dysregulation of cAMP signaling pathway in MT2KO mice

11. Villemagne VL, Dore V, Burnham SC, et al., 2018, Imaging 22. Skribanek Z, Balaspiri L, Mak M, 2001, Interaction between
tau and amyloid-β proteinopathies in Alzheimer disease and synthetic amyloid-beta-peptide (1-40) and its aggregation
other conditions. Nat Rev Neurol, 14: 225–236. inhibitors studied by electrospray ionization mass
spectrometry. J Mass Spectrom, 36: 1226–1229.
https://doi.org/10.1038/nrneurol.2018.9
https://doi.org/10.1002/jms.243
12. Liu CH, Chang HM, Yang YS, et al., 2020, Melatonin
promotes nerve regeneration following end-to-side 23. Zhang YC, Wang ZF, Wang Q, et al., 2004, Melatonin
neurorrhaphy by accelerating cytoskeletal remodeling via attenuates beta-amyloid-induced inhibition of neurofilament
the melatonin receptor-dependent pathway. Neuroscience, expression. Acta Pharmacol Sin, 25: 447–451.
429: 282–292.
24. Ono K, Hasegawa K, Yoshiike Y, et al., 2002,
https://doi.org/10.1016/j.neuroscience.2019.09.009 Nordihydroguaiaretic acid potently breaks down pre-formed
Alzheimer’s beta-amyloid fibrils in vitro. J Neurochem,
13. Liu D, Wei N, Man HY, et al., 2015, The MT2 receptor
stimulates axonogenesis and enhances synaptic transmission 81: 434–440.
by activating Akt signaling. Cell Death Differ, 22: 583–596. https://doi.org/10.1046/j.1471-4159.2002.00904.x
https://doi.org/10.1038/cdd.2014.195 25. Rudnitskaya EA, Maksimova KY, Muraleva NA, et al., 2015,
Beneficial effects of melatonin in a rat model of sporadic
14. Deng YQ, Xu GG, Duan P, et al., 2005, Effects of melatonin
on wortmannin-induced tau hyperphosphorylation. Acta Alzheimer’s disease. Biogerontology, 16: 303–316.
Pharmacol Sin, 26: 519–526. https://doi.org/10.1007/s10522-014-9547-7
https://doi.org/10.1111/j.1745-7254.2005.00102.x 26. Lopez N, Tormo C, De Blas I, et al., 2013, Oxidative stress
in Alzheimer’s disease and mild cognitive impairment with
15. Li XC, Wang ZF, Zhang JX, et al., 2005, Effect of melatonin
on calyculin A-induced tau hyperphosphorylation. Eur J high sensitivity and specificity. J Alzheimers Dis, 33: 823–829.
Pharmacol, 510: 25–30. https://doi.org/10.3233/jad-2012-121528
https://doi.org/10.1016/j.ejphar.2005.01.023 27. Wang X, Wang LP, Tang H, et al., 2014, Acetyl-L-carnitine
rescues scopolamine-induced memory deficits by restoring
16. Li SP, Deng YQ, Wang XC, et al., 2004, Melatonin protects
SH-SY5Y neuroblastoma cells from calyculin A-induced insulin-like growth factor II via decreasing p53 oxidation.
neurofilament impairment and neurotoxicity. J Pineal Res, Neuropharmacology, 76: 80–87.
36: 186–191. https://doi.org/10.1016/j.neuropharm.2013.08.022
https://doi.org/10.1111/j.1600-079x.2004.00116.x 28. Liu J, Ames BN, 2005, Reducing mitochondrial decay
with mitochondrial nutrients to delay and treat cognitive
17. Wang YP, Li XT, Liu SJ, et al., 2004, Melatonin ameliorated
okadaic-acid induced Alzheimer-like lesions. Acta dysfunction, Alzheimer’s disease, and Parkinson’s disease.
Pharmacol Sin, 25: 276–280. Nutr Neurosci, 8: 67–89.
https://doi.org/10.1080/10284150500047161
18. Li Y, Zhang J, Wan J, et al., 2020, Melatonin regulates Aβ
production/clearance balance and Aβ neurotoxicity: 29. Reddy PH, 2006, Mitochondrial oxidative damage in aging
A potential therapeutic molecule for Alzheimer’s disease. and Alzheimer’s disease: Implications for mitochondrially
Biomed Pharmacother, 132: 110887. targeted antioxidant therapeutics. J Biomed Biotechnol,
2006: 31372.
https://doi.org/10.1016/j.biopha.2020.110887
https://doi.org/10.1155/JBB/2006/31372
19. Panmanee J, Nopparat C, Chavanich N, et al., 2015,
Melatonin regulates the transcription of βAPP-cleaving 30. Pena-Bautista C, Baquero M, Vento M, et al., 2019,
secretases mediated through melatonin receptors in human Free radicals in Alzheimer’s disease: Lipid peroxidation
neuroblastoma SH-SY5Y cells. J Pineal Res, 59: 308–320. biomarkers. Clin Chim Acta, 491: 85–90.
https://doi.org/10.1111/jpi.12260 https://doi.org/10.1016/j.cca.2019.01.021
20. Lahiri DK, 1999, Melatonin affects the metabolism of the 31. Savaskan E, Ayoub MA, Ravid R, et al., 2005, Reduced
beta-amyloid precursor protein in different cell types. hippocampal MT2 melatonin receptor expression in
J Pineal Res, 26: 137–146. Alzheimer’s disease. J Pineal Res, 38: 10–16.
https://doi.org/10.1111/j.1600-079x.1999.tb00575.x https://doi.org/10.1111/j.1600-079X.2004.00169.x
21. Song W, Lahiri DK, 1997, Melatonin alters the metabolism 32. Savaskan E, Olivieri G, Meier F, et al., 2002, Increased
of the beta-amyloid precursor protein in the neuroendocrine melatonin 1a-receptor immunoreactivity in the hippocampus
cell line PC12. J Mol Neurosci, 9: 75–92. of Alzheimer’s disease patients. J Pineal Res, 32: 59–62.
https://doi.org/10.1007/BF02736852 https://doi.org/10.1034/j.1600-079x.2002.00841.x

Volume 2 Issue 3 (2023) 10 https://doi.org/10.36922/an.0974